Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 229 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2786 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2022-04-08 | 2022-04-13 | 158342 |
APO-IMATINIB | 400MG | TABLET | Resolved | 2022-04-08 | 2022-06-03 | 158361 |
APO-MOXIFLOXACIN | 400MG | TABLET TABLET | Resolved | 2022-06-06 | 2022-09-06 | 162094 |
APO-ACEBUTOLOL | 400MG | TABLET | Resolved | 2022-07-22 | 2022-09-23 | 165314 |
APO-ACYCLOVIR | 400MG | TABLET | Resolved | 2022-11-14 | 2023-02-09 | 174639 |
APO-IBUPROFEN | 400MG | TABLET | Resolved | 2023-01-06 | 2023-02-09 | 180109 |
APO-MOXIFLOXACIN | 400MG | TABLET TABLET | Resolved | 2023-08-18 | 2023-12-01 | 202397 |
APO-ACYCLOVIR | 400MG | TABLET | Actual shortage | 2023-09-01 | 2023-09-01 | 203566 |
APO-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-19 | 2024-04-19 | 216696 |
APO-IBUPROFEN | 400MG | TABLET | Resolved | 2024-03-15 | 2024-04-05 | 222470 |
APO-MOXIFLOXACIN | 400MG | TABLET TABLET | Actual shortage | 2024-05-03 | 2024-05-03 | 227025 |
APO-AMLODIPINE-ATORVASTATIN | 40MG 10MG | TABLET | Resolved | 2021-05-14 | 2021-05-26 | 139400 |
APO-AMLODIPINE-ATORVASTATIN | 40MG 10MG | TABLET | Resolved | 2022-12-02 | 2023-03-02 | 176924 |
APO-AMLODIPINE-ATORVASTATIN | 40MG 5MG | TABLET | Resolved | 2022-06-06 | 2022-07-22 | 162088 |
APO-SULFATRIM ORAL SUSPENSION | 40MG 8MG | SUSPENSION | Actual shortage | 2017-08-13 | 2017-10-05 | 18991 |
APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2017-03-10 | 2017-07-20 | 61 |
APO-CITALOPRAM | 40MG | TABLET | Resolved | 2017-03-10 | 2017-04-07 | 113 |
APO-ELETRIPTAN | 40MG | TABLET | Resolved | 2017-03-10 | 2020-01-07 | 308 |
APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2017-03-11 | 2017-08-25 | 444 |
APO-VALSARTAN | 40MG | TABLET | Resolved | 2017-03-11 | 2019-03-11 | 573 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-DIPYRIDAMOLE | 75MG | TABLET | Discontinued | 2019-12-20 | 2019-12-21 | 101880 |
APO-FUROSEMIDE | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |